Episode 4

full
Published on:

22nd Jan 2025

Living with POTS, MCAS, and EDS: Lindsay's Health Journey

Lindsay shared her health journey. She discussed her experience of being diagnosed with Postural Orthostatic Tachycardia Syndrome (POTS), Ehlers-Danlos Syndrome (EDS), and Mast Cell Activation Syndrome (MCAS). She described first noticing symptoms in her early 30s, leading to her POTS diagnosis in 2017 after fainting during a tilt table test. Lindsay also shared her battle with breast cancer, undergoing treatment, and successfully overcoming the challenges. In 2022, she encountered a frightening episode of rapid heart rate, trembling, and other distressing symptoms, prompting her to seek help from a functional gastroenterologist. Lindsay explained her ongoing struggle with gut issues, constipation, a dairy allergy, and skin problems, and how she has found relief through dietary adjustments and medication.

Listen for free

Show artwork for The LDN Radio Show About Low Dose Naltrexone

About the Podcast

The LDN Radio Show About Low Dose Naltrexone
Listen to LDN Prescribers, Researchers, Pharmacists from around the world! This is your chance to ask your questions to the experts, please email linda.ldnrt@gmail.com if you have any questions.
Listen to LDN Prescribers, Researchers, Pharmacists from around the world discuss Low Dose Naltrexone.

This is your chance to ask your questions to the experts, please email linda@ldnrt.org with your questions.

The LDN Radio Show is FREE if you would like to make a donation please visit www.ldnresearchtrust.org/donate

About your host

Profile picture for Linda Elsegood

Linda Elsegood

Linda is the founder of the LDN Research Trust established in 2004. She runs the trust raising awareness of LDN, answering with the help of the medical adviser’s, questions from users and the medical profession, helping people around the world find an LDN prescribing doctor. Linda has interviewed so far over 320 LDN Prescribing Doctors, Scientists and Users. Linda has MS and has been taking LDN with great success for MS over the last 10 years.